Operating Lease, Right-of-Use Asset in USD of Propanc Biopharma, Inc. from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Propanc Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q3 2019 to Q3 2025.
  • Propanc Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $56.3K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $56.3K Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $59.4K +$41.6K +234% Jun 30, 2025 10-Q 2025-11-14
Q1 2025 $62.1K May 4, 2025 10-Q 2025-11-14
Q2 2024 $17.8K Jun 30, 2024 10-K 2025-09-29
Q1 2023 $44.5K Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $50.7K Dec 31, 2022 10-Q 2023-02-10
Q3 2022 $53K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $62.5K Jun 30, 2022 10-Q 2023-05-15
Q1 2021 $2.4K -$22.6K -90.4% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $9.7K -$25.7K -72.6% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 $15.8K -$24.5K -60.8% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $21.7K Jun 30, 2020 10-K 2021-09-28
Q1 2020 $25K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $35.4K Dec 31, 2019 10-Q 2020-02-14
Q3 2019 $40.3K Sep 30, 2019 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.